Navigation Links
Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence
Date:4/14/2009

Commercial Managed Care - Managed care plans come in many varieties and serve different purposes. This course looks at the characteristics of the different types of managed care organizations (MCOs), the different types of benefit and formulary design, the various mechanisms that plans use to manage drug utilization and costs, the impact of patent expiration and generic utilization on branded products, tactics health plans use to drive generic utilization, and potential future trends in managed care.
  • Medicare - With the launch of the Medicare Part D drug benefit, Medicare's impact on pharmaceutical and biologic product sales has dramatically increased. This course provides team members with the necessary background to understand and effectively sell to this segment of the market, including the four key components of Medicare: Parts A, B, C, & D, the characteristics of the Medicare population, the current structure and potential changes to the Part D drug benefit, and the common questions about the Medicare program.
  • Medicaid - The role and importance of Medicaid has been transformed by the Medicare Part D drug benefit. This course helps team members understand how this program has evolved and how it is managed. Topics covered in this course include, understanding the characteristics of the Medicaid population, changes to Medicaid as a result of Medicare Part D, the role of preferred drugs lists in Medicaid utilization management, and the priorities and challenges for the government in managing and paying for drugs.
  • Specialty Pharmacy - Specialty products are under increasing financial pressure in the current reimbursement environment. This course helps team members understand the management structure and economics of a physician practice that utilizes specialty products, including the day-to-day roles and responsibilities of practice managers, as well as their key challenges, the
    '/>"/>

  • SOURCE Pharmaceutical Institute
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Researchs 100th Annual Meeting
    2. Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals
    3. Process Analytical Technology (PAT): The Official Language of Pharmaceutical Outsourcing
    4. Marinus Pharmaceuticals Raises $20 Million in Series B Financing
    5. OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia
    6. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
    7. Gemin X Pharmaceuticals Selects and Deploys Clinical Force CTMS
    8. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
    9. VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
    10. Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier
    11. Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/3/2015)... WESTWOOD, Mass. , Aug. 3, 2015  Merck ... company for innovative and top-quality high-tech products in the ... together with the US-based company Nano-C, their development and ... field of organic photovoltaics (OPV). Merck KGaA, Darmstadt, ... participate in the growing OPV sector. Novel ...
    (Date:8/3/2015)... , Aug. 3, 2015   Intrexon Corporation ... first half and second quarter 2015 financial results after ... 2015.  The Company will host a conference call at ... a general business update. The conference call ... 1-412-902-4262 (International), and asking to join the "Intrexon Corporation ...
    (Date:7/31/2015)... July 31, 2015 In today,s fast ... help them drive positive health outcomes, improve profitability ... of patient care in their communities. At ThoughtSpot ... and conference, AmerisourceBergen announced a new set of ... Administration Organization and help independent pharmacies endure the ...
    (Date:7/30/2015)... ... 2015 , ... Ralco is honored to announce that it is the primary ... held August 5-9 in Marshall. The Ralco Enrichment Center is an interactive experience where ... impacts their daily lives. This unique exhibit also features a birthing center for fair ...
    Breaking Biology Technology:Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 4Intrexon to Announce First Half and Second Quarter 2015 Financial Results and Host Conference Call on August 10th 2AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 2AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 3Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2
    ... Focusing On Diagnostic Products and Target Validation, ... Inc. announced today,that SomaLogic and Otsuka Pharmaceutical ... use SomaLogic,s proprietary aptamer technology,to discover and ... research,tools that will enhance Otsuka,s pharmaceutical discovery ...
    ... Barr Pharmaceuticals,Inc. (NYSE: BRL ) today announced ... approval from the U.S. Food and Drug,Administration (FDA) ... and market a generic version of Yasmin(R) (drospirenone ... marketed,by Bayer Schering Pharma, AG., On March ...
    ... Planting Season, BEIJING and CLAREMONT, Calif., May ... Bulletin Board: KWBT),announced revenues for the first quarter ... of 57.8% above revenues of $1,384,093 for the ... is due to the expansion in Kiwa,s,bio-fertilizer and ...
    Cached Biology Technology:SomaLogic and Otsuka Enter Into Research Collaboration 2SomaLogic and Otsuka Enter Into Research Collaboration 3Barr Announces Approval of Generic Yasmin(R) 2Barr Announces Approval of Generic Yasmin(R) 3Kiwa Bio-Tech 1st Quarter Revenues Increase 57.8% - $2.18 Million 2Kiwa Bio-Tech 1st Quarter Revenues Increase 57.8% - $2.18 Million 3
    (Date:7/31/2015)... , 31 de julio de 2015 BGI llevará ... www.icg-10.org ) del 22 al 25 de octubre de ... La conferencia celebra su décimo aniversario este año. ... en una de las reuniones anuales más influyentes del ... una de las conferencias científicas más dinámicas, entusiastas y ...
    (Date:7/31/2015)... OXFORD, Conn. , Jul. 31, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... announces that it has filed provisional patent 62/198989 for ... This invention highlights a method to advance crypto-currencies ... technology by introducing a common, uniform way to manage ...
    (Date:7/23/2015)... (NASDAQ: AWRE ), a leading supplier of biometrics software ... ended June 30, 2015.  Revenue for the ... 33% compared to $6.8 million in the same quarter last ... $0.3 million, or $0.01 per diluted share, which compared to ... period a year ago.  Lower revenue and ...
    Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
    ... University of Illinois weed scientist Patrick Tranel got more genetic ... lab. The genetic information was obtained using pyrosequencing technology in ... sequence will allow scientists to study herbicide resistance in waterhemp. ... refers to as "important species" such as humans, cows, fruit ...
    ... 5 August 2009 - It is important to understand ... be resilient under conditions of extreme stress, such as ... Dr. Charles A. Morgan III and his colleagues from ... have worked closely with collaborators at the Special Forces ...
    ... U.S Department of Energy Secretary Steven Chu announced ... from the American Recovery and Reinvestment Act will go ... of DOE,s national laboratories in six states will be ... learning across the nation. "These new initiatives ...
    Cached Biology News:Understanding how weeds are resistant to herbicides 2Understanding how weeds are resistant to herbicides 3Understanding how weeds are resistant to herbicides 4Hormone levels contribute to stress resilience 2Obama administration announces more than $327 million in Recovery Act funding for science research 2Obama administration announces more than $327 million in Recovery Act funding for science research 3
    Recognizes Human Connexin 45. Due to sequence homologies, this antibody is also expected to react with canine (100% homology) and mouse (92% homology) Connexin 45. Also confirmed to work on rat C6 c...
    ... a hydrophobic barrier pen for immunohistochemistry and ... with frozen or paraffin-embedded tissue sections mounted ... a heat-stable, water-repellent barrier that keeps staining ... mixing of reagents when differentially staining two ...
    ...
    ...
    Biology Products: